-
Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support
Mar 10, 2025, 14:00 PM -
Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach
Mar 10, 2025, 14:00 PM -
Trends in Breast Cancer Drugs Approved by the US Food and Drug Administration, 1980-2024
Mar 10, 2025, 14:00 PM -
Developing a Large Language Model-Based Simulation for P&T Committees: Methodology and Inputs for Realistic Dynamics
Mar 10, 2025, 14:00 PM -
Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil
Mar 10, 2025, 14:00 PM -
Which Strategy is More Effective in Patients with Rheumatoid Arthritis (RA) and Metotrexate Failure: Adding Leflunomide or TNFi?
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Associated Costs in Patients With Transthyretin Cardiac Amyloidosis and Non-amyloid Heart Failure
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Real-World Persistence to Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis in a Commercial and Medicare Advantage Population
Mar 10, 2025, 14:00 PM -
Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years
Mar 10, 2025, 14:00 PM -
Empowering Healthcare Decision-Making: Leveraging Standardized Template for Enhanced Reliability and Efficiency in Budget Impact Analysis by Health Technology Assessment Agency
Mar 10, 2025, 14:00 PM -
Treatment Patterns Post-CAR T Cell Therapy in Patients With Hematologic Malignancies: A Real-World US Study
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients With Fragile X Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study
Mar 10, 2025, 14:00 PM -
Harnessing Digital Measures of Physical Function in Neurological Conditions: Findings From a Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Treatment Experience and Other Health and Social Characteristics Among Patients With Cancer From a Large US Population-Based Survey
Mar 10, 2025, 14:00 PM -
Economic Burden of Opioid-Induced Constipation Among Patients With or Without Cancer in the United States
Mar 10, 2025, 14:00 PM -
The Use of Social Media Listening to Collect Oncology-Specific Patient Experience Data: A Scoping Review
Mar 10, 2025, 14:00 PM -
Comparison of Meaningful Score Difference Estimates From Longitudinal Item Response Theory and Anchor-Based Methods
Mar 10, 2025, 14:00 PM -
Why It Is Still Important to Ensure the Price is Right: Updates to Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM
